Watch out, do not misinterpret slide #12 about the SPA protocol, the protocol remains to be signed. When I took a quick glance at the presentation this morning I noted that there was a change: the presentation from April was shifted to the present one for June.
But there are many new slides that shows the path forward to phase 3 in the US and - also - distinct data from the earlier presentations on the top line data from the Amiket CIPN-trial.
There is a contrast between the distinct data about the Amiket trial in cancer pain and that CO have no text at all on the ordinary homepage about the last trial. :-)
We have a two or three stage news development, fast track and SPA-protocol, the detailed Amiket-data revealing the acctual efficacy (compaired to market leader in the broad diagnosis.) and, not the least, the Amiket deal. All this summer.
Like in last fall we have been given an extra opportunity these days. Good luck to you all!